TokenPost·
Intellia Therapeutics Revenue Misses Estimates as GAAP Loss Per Share Hits $0.91
Total revenue was $7.16 million, $2.61 million below estimates. Collaboration revenue fell 48% year over year to $7.2 million.
More news
- TokenPostRiot Lease Requires Anthropic Consent for Voluntary Corsicana Power Cuts
- Crypto BriefingCircle’s Kris Gower makes the case for Arc and USDC in securities lending
- DecryptWhy a Hyperliquid Treasury Firm Wants to Become a US Futures Broker
- TokenPostdeVere CEO Says Investors Will Weigh AI Revenue After Big Tech Selloff
- CryptopolitanOnly crypto firms still let OKXICE tokenize their stock
- TokenPostMARA Schedules Third-Quarter Results Call for Monday, Nov. 9